Viewing StudyNCT02603809



Ignite Creation Date: 2024-05-06 @ 7:49 AM
Last Modification Date: 2024-10-26 @ 11:52 AM
Study NCT ID: NCT02603809
Status: COMPLETED
Last Update Posted: 2022-11-23
First Post: 2015-11-09

Brief Title: Dose-finding Study With ACT-132577 Aprocitentan in Participants With Essential Hypertension
Sponsor: Idorsia Pharmaceuticals Ltd
Organization: Idorsia Pharmaceuticals Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-12-14
Start Date Type: ACTUAL
Primary Completion Date: 2017-02-28
Primary Completion Date Type: ACTUAL
Completion Date: 2017-04-07
Completion Date Type: ACTUAL
First Submit Date: 2015-11-09
First Submit QC Date: November 11 2015
Study First Post Date: 2015-11-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2020-04-13
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2018-03-26
Disp First Submit QC Date: March 28 2018
Disp First Post Date: 2018-03-29
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2022-11-22
Last Update Post Date: 2022-11-23
Last Update Post Date Type: ACTUAL